Mimedx (MDXG) Cash from Investing Activities (QoQ) (2011 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.75% |
| Mar 31, 2026 | -1,584.18% |
| Dec 31, 2025 | 93.63% |
| Sep 30, 2025 | -492.78% |
| Jun 30, 2025 | -118.47% |
| Mar 31, 2025 | 85.33% |
| Dec 31, 2024 | -2,548.67% |
| Sep 30, 2024 | 112.49% |
| Jun 30, 2024 | 84.98% |
| Mar 31, 2024 | -1,152.39% |
| Dec 31, 2023 | 25.89% |
| Sep 30, 2023 | -86.49% |
| Jun 30, 2023 | 48.60% |
| Mar 31, 2023 | 60.39% |
| Dec 31, 2022 | -356.95% |
| Sep 30, 2022 | 12.82% |
| Jun 30, 2022 | -189.86% |
| Mar 31, 2022 | 52.87% |
| Dec 31, 2021 | 45.86% |
| Sep 30, 2021 | -37.44% |